Certuity LLC Purchases 602 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Certuity LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 45.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,932 shares of the medical equipment provider's stock after buying an additional 602 shares during the period. Certuity LLC's holdings in Intuitive Surgical were worth $1,008,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in ISRG. Leavell Investment Management Inc. increased its position in shares of Intuitive Surgical by 0.7% during the fourth quarter. Leavell Investment Management Inc. now owns 3,556 shares of the medical equipment provider's stock valued at $1,856,000 after purchasing an additional 25 shares during the period. Portfolio Design Labs LLC increased its position in shares of Intuitive Surgical by 14.7% during the fourth quarter. Portfolio Design Labs LLC now owns 4,035 shares of the medical equipment provider's stock valued at $2,106,000 after purchasing an additional 516 shares during the period. New Republic Capital LLC increased its position in shares of Intuitive Surgical by 34.9% during the fourth quarter. New Republic Capital LLC now owns 568 shares of the medical equipment provider's stock valued at $296,000 after purchasing an additional 147 shares during the period. Sovran Advisors LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $250,000. Finally, Stonebridge Financial Group LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $343,000. 83.64% of the stock is owned by institutional investors.

Remove Ads

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $4.16 during midday trading on Friday, reaching $595.55. 1,188,781 shares of the company's stock were exchanged, compared to its average volume of 1,979,754. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market cap of $212.12 billion, a price-to-earnings ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39. The stock's 50-day simple moving average is $559.48 and its 200 day simple moving average is $519.06.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Barclays boosted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, UBS Group boosted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,348 shares of company stock worth $3,587,582. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.